By InvitationPhase 2

Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings

United States, Germany, Japan400 participantsStarted 2025-10-06

Plain-language summary

This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Age 18-75 years Able to provide informed consent Facility staff, clinical auditors, ESG observers, or coalition stakeholders Willing to interact with humanoid robotics in clinical workflows Available for biometric feedback and observational logging over 90 days Exclusion Criteria: \- Cognitive impairment preventing informed consent Active infectious disease requiring isolation Prior adverse reaction to biotech-enhanced robotics Involvement in conflicting clinical trials Inability to comply with protocol procedures or coalition transparency requirements

What they're measuring

Biometric Audit Score ≥85 Across Five Performance Dimensions

Timeframe: Measured at Day 30 Post-Deployment

Trial details

NCT IDNCT07214896

SponsorTruway Health, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2031-10-06

View on ClinicalTrials.gov More Mobility Impairment trials